611 related articles for article (PubMed ID: 11654438)
1. Federal report says protection of human subjects is threatened by numerous factors.
Maloney DM
Hum Res Rep; 1996 May; 11(5):1-3. PubMed ID: 11654438
[No Abstract] [Full Text] [Related]
2. Federal investigation concludes that institutional review boards are in trouble.
Maloney DM
Hum Res Rep; 1998 Aug; 13(8):1-2. PubMed ID: 11657190
[No Abstract] [Full Text] [Related]
3. Research compliance changes will affect rules on protection of human subjects.
Maloney DM
Hum Res Rep; 1999 May; 14(5):1-2. PubMed ID: 11657776
[No Abstract] [Full Text] [Related]
4. Half-full or half-empty? Evaluating IRB performance.
Mishkin B; Ariand N
Prof Ethics Rep; 1998; 11(3):4-7. PubMed ID: 11657925
[No Abstract] [Full Text] [Related]
5. The concept of the IRB and bureaucratic reality: an exchange of letters.
van Eys J; Levine RJ
IRB; 1984; 6(4):8-10. PubMed ID: 11649563
[No Abstract] [Full Text] [Related]
6. Report says institutional review boards are conducting inadequate reviews.
Maloney DM
Hum Res Rep; 1998 Sep; 13(9):1-2. PubMed ID: 11660603
[No Abstract] [Full Text] [Related]
7. Institutional review boards not paying enough attention to active research projects.
Maloney DM
Hum Res Rep; 1998 Nov; 13(11):1-2. PubMed ID: 11657741
[No Abstract] [Full Text] [Related]
8. IRBs and pharmaceutical company funding of research.
Jellinek MS; Levine RJ
IRB; 1982 Oct; 4(8):9-10. PubMed ID: 11651693
[No Abstract] [Full Text] [Related]
9. Exempt research: procedures in the intramural research program of the National Institutes of Health.
Wichman A; Mills D; Sandler AL
IRB; 1996; 18(2):3-5. PubMed ID: 11654755
[No Abstract] [Full Text] [Related]
10. Beyond localism: a proposal for a National Research Review Board.
Levine C; Caplan AL
IRB; 1986; 8(2):7-9. PubMed ID: 11649751
[No Abstract] [Full Text] [Related]
11. Institutional animal care and use committees.
Britt DP
ATLA Abstr; 1986 Mar; 13(3):236-9. PubMed ID: 11649839
[No Abstract] [Full Text] [Related]
12. Protection of human subjects.
United States
Code Fed Regul Shipping; 1982 Oct; Part 46, Sections 46.101 to 46.306():. PubMed ID: 11660819
[No Abstract] [Full Text] [Related]
13. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.
Weijer C
IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912
[No Abstract] [Full Text] [Related]
14. IRBs and epidemiologic research: how inappropriate restrictions hamper studies.
Cann CI; Rothman KJ
IRB; 1984; 6(4):5-7. PubMed ID: 11649562
[No Abstract] [Full Text] [Related]
15. The Food and Drug Administration's role in the protection of human subjects.
Nightingale SL
IRB; 1983; 5(1):6-9. PubMed ID: 11649511
[No Abstract] [Full Text] [Related]
16. Special informed consent requirements are included in protocol review procedures.
Maloney DM
Hum Res Rep; 1995 Jul; 10(7):1-2. PubMed ID: 11654274
[No Abstract] [Full Text] [Related]
17. The regulation of human experimentation in the United States--a personal odyssey.
Katz J
IRB; 1987; 9(1):1-6. PubMed ID: 11649890
[No Abstract] [Full Text] [Related]
18. The history of institutional review boards.
Sherman M; Van Vleet JD
Regul Aff J; 1991; 3():615-27. PubMed ID: 11651491
[No Abstract] [Full Text] [Related]
19. Multicenter trials and subject eligibility: should local IRBs play a role?
Freedman B
IRB; 1994; 16(1-2):1-6. PubMed ID: 11652320
[No Abstract] [Full Text] [Related]
20. Monitoring of drug tests is faulted.
Eichenwald K
N Y Times Web; 1998 Jun; ():A14. PubMed ID: 11647564
[No Abstract] [Full Text] [Related]
[Next] [New Search]
